Technology News and Research

RSS

Clinical studies participated by three investigators to be presented at ASH Annual Meeting and Exposition

US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.

4 Dec 2010

Shrink's MetalFluor technology on front cover of Applied Physics Letters

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that Shrink's MetalFluor™ technology was studied, reported on and made the front cover of the November issue of Applied Physics Letters.

4 Dec 2010

Conference focuses on new molecular, mechanical solutions to improve surgeries

A two-day conference at the University of Chicago Medical Center is designed to offer surgeons a peek at the profession's future by focusing on new molecular and mechanical solutions to three age-old problems: preventing the breakdown of anastomoses (the surgically created connections between blood vessels), improving tissue healing after surgery and developing new tools to test and sharpen surgical skills.

4 Dec 2010

ETP, EF announce latest grant recipients of New Therapy Grants Program

The Epilepsy Therapy Project and the Epilepsy Foundation today announced the latest grant recipients of their New Therapy Grants Program, a unique joint venture of two non-profit epilepsy organizations, to advance promising epilepsy research in clinical development.

4 Dec 2010

Pharnext receives French approval for Pleodrug Phase II clinical trial in Charcot-Marie Tooth disease type 1A

Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.

4 Dec 2010

United Science licenses ion selective electrode sensor technology from University of Minnesota

United Science, a Minnesota startup company, has licensed sensor technology developed at the University of Minnesota that could prevent toxic byproducts of mining and other industries from ending up in the environment and improve productivity at the same time.

4 Dec 2010

Neurostimulation effective for management of chronic pain

St. Jude Medical, Inc., a global medical device company, today announced two-year results in a post-market clinical study evaluating neurostimulation (spinal cord stimulation) for the management of chronic low back pain. Presented at the 14th annual North American Neuromodulation Society (NANS) meeting in Las Vegas, the study found that 70 percent of neurostimulation patients reported overall pain relief of 50 percent or better at their final two-year visit.

4 Dec 2010

URMC's Cone Beam CT scanner studies presented at RSNA 2010

While questions persist about the best ways to detect breast cancer early, a CT imaging system developed at the University of Rochester Medical Center and first unveiled five years ago is in a better position today to enter the fray -- at least in a supporting role to conventional mammography.

4 Dec 2010

IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

The Infectious Disease Research Institute has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority. IDRI's work will focus on development of adjuvant formulations with options up to $8.5 million over three years when further development and manufacture of priority candidates are approved by the agency.

4 Dec 2010

Omnicell to unveil new solutions at 2010 ASHP midyear conference

Omnicell, Inc., a leading provider of medication management solutions to acute healthcare facilities, will display its latest innovations during the 45th American Society for Health-System Pharmacists Midyear Clinical Meeting and Exhibition from December 6-8 in Anaheim, California.

From Omnicell, Inc. 4 Dec 2010

Information technology could improve prevention, treatment of depression

Could information technology and data mining techniques be used to improve the diagnosis and treatment of depression? That's the question scientists in Australia hope to have answered in a forthcoming issue of the International Journal of Functional Informatics and Personalised Medicine.

4 Dec 2010

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

The Infectious Disease Research Institute (IDRI) today announced it has received a $790,200 grant from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services. The grant enables technology transfer between IDRI and the Cantacuzino National Institute of Research and Development for Microbiology and Immunology (Bucharest, Romania), with the goal of producing a pandemic flu vaccine.

4 Dec 2010

EHSI announces acquisition of Rotary Cell Culture System

Emerging Healthcare Solutions, Inc. announced today that it has acquired a Rotary Cell Culture System, or bioreactor, developed using revolutionary NASA research in the field of microgravity.

4 Dec 2010

HIV/AIDS opinions

"Promising scientific developments to prevent AIDS, not just treat its victims, have sparked hope among health officials, researchers and advocacy groups struggling to control the epidemic. Unfortunately, the global recession and soaring deficits in advanced nations have made it unlikely that sufficient money will be available to fully seize the new opportunities," according to a New York Times editorial, which postures, "[s]ome agonizing choices will have to be made."

4 Dec 2010

Merck plans to acquire SmartCells

Today pharmaceutical company, Merck & Co., Inc. announced it will acquire SmartCells, Inc., a private biotech developing a glucose-responsive insulin whose proof-of-concept preclinical trials were partially funded by the Juvenile Diabetes Research Foundation.

4 Dec 2010

LifeSpan TR1200i folding treadmill named 'Best New Treadmill'

The LifeSpan TR1200i folding treadmill was named "Best New Treadmill" by Treadmill Doctor in their 2011 fitness equipment reviews. Fitness Professor Review also selected the LifeSpan TR1200i, made by PCE Health and Fitness (www.lifespanfitness.com) as its choice for "Best Treadmill under $1000."

3 Dec 2010

Toshiba offers new classes to educate technologists

As advanced applications for imaging technology continue to develop at a fast pace, it is critical that the medical community have access to education opportunities to enhance the use of these new tools. Toshiba America Medical Systems, Inc.'s Education Center in Irvine, Calif., is now offering two new classes: "Advanced CT Imaging for Technologists" and "Advanced Non-Contrast MRA" to educate technologists on the latest applications available with their state-of-the-art Toshiba technology.

3 Dec 2010

FDA Advisory Panel recommends approval of Solesta for bowel incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel recommended approval of Solesta™ as a treatment for fecal (bowel) incontinence, a condition afflicting many Americans, primarily women.

3 Dec 2010

NetDimensions releases Enterprise Knowledge Platform version 6.3

NetDimensions, a global provider of performance, knowledge and Learning Management Systems (LMS), announced today the release of version 6.3 of the Enterprise Knowledge Platform (EKP), the company's award-winning learning management system.

3 Dec 2010

Columbia's professor receives 2010 Garfield Economic Impact Award

The 2010 Garfield Economic Impact Award was presented today to Frank R. Lichtenberg, PhD, of Columbia Business School. Research!America has presented this award since 2002, to recognize the outstanding work of economists who demonstrate how medical and health research impacts the economy. The award is supported by a grant from Merck & Co., Inc., and by the Eugene Garfield Foundation.

3 Dec 2010